The legacy of the blue pill offers a complex case study for investors eyeing drug companies. While early sales were astounding, recent patent expiry and the rise of generic versions have severely impacted https://aoifezopb900938.tinyblogging.com/the-blue-pill-and-the-pharmaceutical-industry-a-risky-investment-85178756